Objective: To study the association between plasma antioxidants (b-carotene and a-tocopherol) and lung function in Dutch adults aged 20 ± 59 y. Design: Cross-sectional. Setting: Population-based study. Subjects: A random sample (n 367) was drawn from all participants (men and women) aged 20 ± 59 y with reproducible lung function measurements in 1995. Intervention: Completion of general questionnaire and physical examination. Main outcome measurements: Forced expiratory volume in 1 s (FEV 1 ), forced vital capacity (FVC) and plasma levels of b-carotene and a-tocopherol. Results: Subjects with a high plasma b-carotene level (90th percentile, that is 0.57 mmolaL) tended to have a higher FEV 1 (73 ml, s.e.m. 60 ml; P 0.22) and a higher FVC (147 ml, s.e.m. 76 ml; P 0.05) than subjects with a low plasma b-carotene level (10th percentile, that is 0.11 mmolaL) after adjustment for age, height, gender, smoking status, pack-years of smoking and alcohol consumption. There was no difference in lung function between subjects with high and low plasma a-tocopherol concentrations.
Introduction
Antioxidants, such as vitamins C, E and b-carotene may bene®cially affect lung function (Burney, 1995; Hatch, 1995; Sridhar, 1995) . These antioxidants can scavenge endogenous andaor environmental oxidants in the lung and could, therefore, partly prevent a permanent loss of lung function over time (Heffner & Repine, 1989) .
To elucidate a possible relation between antioxidants and respiratory disease it is important to investigate the association between blood levels of antioxidants and lung function, because blood levels of antioxidants are likely to be better markers of exposure in the lung tissue than dietary intake of antioxidants measured by questionnaire (Hunter, 1990; Willett, 1990; Redlich et al, 1996) . Furthermore, lung function is thought to be a more objective measurement than self-reported respiratory symptoms. However, most studies so far have been investigating the relations between dietary antioxidants and lung function (Schwartz & Weiss, 1994; Shahar et al, 1994; Britton et al, 1995; Dow et al, 1996; Ness et al, 1996; Grievink et al, 1998) . To our knowledge, there has only been one cross-sectional study (798 men) on blood levels of b-carotene in relation to lung function suggesting a bene®cial association (Chuwers et al, 1997) . Another study (83 men) did not show associations between blood levels of antioxidants (b-carotene and a-tocopherol) and the development of airway obstruction (forced expiratory volume in ls, FEV,`75% forced vital capacity, FVC) during 5 subsequent years (Morabia et al, 1990) . Thus, very few studies have investigated blood levels of antioxidants (b-carotene and a-tocopherol) in relation to lung function.
Previously, we found a positive association between dietary vitamin C and b-carotene but not for dietary vitamin E with lung function in a large sample of Dutch adults measured in 1994 and 1995 (Grievink et al, 1998) . Data on plasma antioxidants from a random subsample of 1995 recently became available and we are therefore now able to study the relation between the plasma b-carotene and a-tocopherol and lung function.
Methods

Study population
A random sample was drawn from the MORGEN-study in 1995 (the monitoring project on risk factors and health in the Netherlands). This is a cross-sectional investigation on the prevalence of risk factors for chronic diseases in a randomly selected sample of the Dutch population aged 20 ± 59 y in three towns in the Netherlands (Amsterdam, Doetinchem and Maastricht). The MORGEN-study as a whole (from 1993 through 1997) was approved by the Medical Ethical Committee. The random sample was selected from a total of 4238 subjects with plasma samples in 1995 strati®ed according to gender and age (four 10-y age categories) resulting in eight strata of equal size (n 56). In the resulting 448 subjects, plasma concentrations of a-tocopherol and b-carotene were determined.
Data collection
All respondents from the MORGEN-study ®lled out a general and a semi-quantitative food frequency questionnaire and underwent a physical examination (Grievink et al, 1998; Ocke Â et al, 1997a Ocke Â et al, , 1997b . The general questionnaire provided information about demographic variables; life-style factors, such as smoking (smoking status and pack-years of smoking), physical activity (Pols et al, 1998) and alcohol consumption (non-drinkers, light drinkers: b 0 ± 3 glasses a day, moderate drinkers: more than 3 glasses a day); environmental factors such as dampness of the house; respiratory symptoms (selected from the Dutch part of the European Community Respiratory Health Survey; Burney et al, 1994; Kerkhof et al, 1994) and the presence of other chronic diseases. The physical examination included measurements of height, weight and lung function. In addition, blood (non-fasting) was collected in all subjects for routine measurements of plasma total cholesterol and glucose. Plasma antioxidants (a-tocopherol and b-carotene) were determined in the random sample.
Blood specimens were collected in ethylene diamine tetraacetic acid (EDTA) vacutainer tubes and stored in the refrigerator shielded from the light. Within 4 h after collection, the blood was centrifuged to obtain plasma. Aliquots of plasma were stored at 7 20 C for 6 months or less. After that, plasma samples were stored at 7 80 C at the National Institute of Public Health and the Environment (RIVM). Concentrations of a-tocopherol and b-carotene in each subject were measured by reverse-phase high-performance liquid chromatography (HPLC) in one run. The method was modi®ed as described by Hess and co-workers (Hess et al, 1991) . The coef®cient of variation of the HPLC measurement was 4.1% for plasma b-carotene and 3.1% for plasma a-tocopherol. Due to reasons that occurred randomly, such as not having enough plasma or a defective HPLC device, plasma antioxidant levels could not be determined in nine subjects.
Lung function was measured with a heated pneumotachometer (Jaeger, Germany) (Grievink et al, 1998) . No lung function data was available for 34 subjects because of practical reasons, such as non-availability of lung function devices, time constraints, etc. All subjects who did not achieve at least three technically acceptable manoeuvres, such as manoeuvres with cough, a hesitant start or an early termination were excluded from analysis. Additionally, those subjects who could not perform two reproducible manoeuvres according to ERS 1993 criteria (Quanjer et al, 1993 were excluded from analyses. Analyses were based on the maximum value of the reproducible manoeuvres of FEV 1 and FVC.
Statistical analysis
Models for FEV 1 and FVC were ®tted with multiple linear regression (SAS Institute Inc., 1996) . We used the following basic adjusted model: FEV 1 or FVC divided by height squared as the dependent variable with age, age squared and gender as independent variables. This was the best predictive model and was determined in another publication on all subjects (n 6555) with reproducible lung function measurements during the years of 1994 and 1995 (Grievink et al, 1998) . The shape of the relation between each plasma antioxidant and lung function was investigated by classifying the independent variables (plasma antioxidants) into quintiles of the total population. Since no essential deviation from linearity was observed, plasma antioxidants b-carotene and a-tocopherol were entered as continuous independent variables into the regression model. Regression coef®cients (in ml) were calculated for a standard height of 1.70 m and were expressed as the difference in FEV 1 or FVC between the 90th percentile and the 10th percentile of plasma antioxidant concentration.
We evaluated the effect of the following potential confounders on the association between plasma antioxidants and lung function: pack-years of smoking, smoking status, educational level, body mass index (BMI), physical activity, plasma total cholesterol, dietary antioxidants (vitamins C, E and b-carotene) and alcohol consumption. We could not consider heavy alcohol consumption ( b 6 glassesaday) because of the small percentage (2%) present in this sample. In addition, we were not able to perform statistical evaluation of the differences in effect between smoking status because of the small number in each group.
Results
Plasma levels of b-carotene and a-tocopherol could be determined in 439 out of the 448 subjects. Of those, 34 subjects did not perform a lung function measurement and six subjects had missing values for pack years of smoking. Of the remaining 399 subjects, 385 subjects (96%) had at least three technically acceptable lung function manoeuvres, of which 367 subjects had reproducible measurements for FEV 1 and 369 subjects had reproducible measurements for FVC.
Subjects who were excluded from analyses because they had not performed a lung function test (n 34) or if they did not meet acceptability and reproducibility criteria for FEV 1 (n 32) or FVC (n 30) were older, less physically active, had a lower educational level and higher BMI than those subjects who were included in the analyses (results not shown). Table 1 shows the characteristics of the study population. Mean age was 40 years and about one-third were currently smoking. About 40% did not consume alcoholic drinks. Table 2 presents the mean lung function adjusted for age, height and gender and the crude plasma antioxidant levels. Mean lung function was higher in men, while the mean plasma level for b-carotene was higher in women.
Adjustment for educational level, BMI, physical activity and plasma total cholesterol did not essentially change the regression coef®cients of plasma antioxidants on lung function. To simplify the regression model, these variables were not included in the adjusted models. Smoking status and pack-years of smoking were both associated with lung function and with plasma antioxidant concentrations Table 3 presents the association between plasma bcarotene and lung function. After adjustment for age, height, gender, smoking and alcohol consumption, subjects with a high plasma b-carotene level had a slightly higher FEV 1 but this was not statistically signi®cant (P 0.22) compared to subjects with a low plasma level of b-carotene. The age, height and gender adjusted difference in FEV 1 between subjects with a high and a low plasma bcarotene level was borderline statistically signi®cant (mean difference 107 ml, s.e.m. 60 ml; P 0.07). The magnitude of this difference decreased by more than a half (52 ml) after adjustment for pack-years of smoking and increased slightly (73 ml) after additional adjustment for alcohol consumption. After adjustment for age, height, gender, smoking and alcohol consumption, subjects with a high plasma b-carotene concentration had a borderline signi®-cantly higher FVC (147 ml, s.e.m. 76 ml; P 0.05) compared to subjects with low levels of plasma b-carotene.
The adjusted difference for FEV 1 and FVC between high and low plasma a-tocopherol concentration was not statistically signi®cant different from zero (Table 3) .
Adjustment for dietary antioxidants (vitamins C, E and b-carotene) did not essentially change the associations between plasma antioxidants and lung function (results not shown).
Discussion
Subjects with a high plasma b-carotene concentration had a higher FVC compared to subjects with a low plasma b-carotene concentration which was borderline statistically signi®cant. A higher FEV 1 for a high vs a low plasma b-carotene level tended to be observed but this was not statistically signi®cant. Subjects with a high plasma atocopherol level did not have a higher lung function than subjects with low levels of plasma a-tocopherol. One or more of the following respiratory symptoms: cough, phlegm, productive cough, wheeze, shortness of breath, nocturnal attacks of shortness of breath, ever asthma. Regression coef®cients are presented as a difference in FEV 1 and FVC (in ml for a height of 1.70 m) between subjects in the 90th percentile and those in the 10th percentile of antioxidant levels, that is, respectively 0.57 mmolal and 0.11 mmolal for b-carotene and 42.3 mmolal and 20.2 mmolal of a-tocopherol. b See methods for exact adjustment. Smoking adjustment: pack-years of smoking (zero for never smokers) and smoking status (only for overall group). d Alcohol adjustment: alcohol consumption (dummies low or moderate vs none).
e P`0.10.
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Selection bias may have occurred in this random sample because subjects who did not have a lung function measurement (n 34) or did not ful®l ERS criteria (n 32) were excluded from analysis. However, the reason for not having a lung function measurement was practical and occurred randomly because of non-availability of lung function devices and time constraints suggesting that lung function was not likely to be different. In addition, plasma levels of antioxidants were also not different in subjects with or without lung function measurements, so selection bias did probably not occur in this group. Subjects who did not ful®l ERS criteria have been suggested to have a lower estimated lung function (Eisen & Robins, 1986) . However, plasma antioxidant levels were not consistently different in subjects who were excluded or included in the analysis. Therefore, selection bias probably did not have an in¯uen-tial impact on the results of the present study.
Alcohol consumption appeared to be a confounder in the association between plasma b-carotene and lung function. We observed that moderate alcohol consumption vs no alcohol consumption was associated with a higher FEV 1 and FVC. Two other studies suggested that a moderate intake of alcohol compared to a low intake was associated with higher FVC (Cohen et al, 1980) and that smokers who were consuming moderate alcohol had a better lung function (Rehm et al, 1985) . A moderate alcohol consumption showed also a protective effect against the development of non-speci®c lung disease (Miedema et al, 1993) . The present study further showed that the concentration of plasma b-carotene was lower in subjects with moderate alcohol consumption. This was also observed in other studies (Stryker et al, 1988 , Brady et al, 1996 . So studies investigating the association between plasma b-carotene and lung function that do not adjust for alcohol consumption may underestimate this association if alcohol consumption is associated with lung function, which is still a point of discussion in the literature.
Body mass index was not a confounder in the association between plasma antioxidants and lung function. However, we were not able to consider the confounding effect of body composition. So we can not exclude that differences in muscle mass might partly explain our observed association between plasma b-carotene and lung function.
A high vs a low plasma concentration of b-carotene may be related to a higher lung function if the storage time of the plasma at 7 20 C was shorter in those subjects with a higher lung function. A stability study showed that plasma concentrations of b-carotene and a-tocopherol were not affected by storage at 7 20 C up to 180 days (Ocke Â et al, 1995) . The mean storage time at 7 20 C of about half of our plasma samples was 80 days (range 14 ± 162 days). The other samples were directly stored at 7 80 C. In addition, storage time at 7 20 C was not essentially different for subjects with a high vs a low lung function suggesting that our results on plasma b-carotene and lung function were not attenuated by storage time.
The magnitude of the association between plasma bcarotene and lung function in our study can be compared with one other cross-sectional study among 798 men who had been exposed to asbestos and were mostly former (63%) and current smokers (22%) (Chuwers et al, 1997) . In that study, a difference in the concentration of serum bcarotene of 0.29 mmolal was signi®cantly associated with a 90 ml higher FEV, and an 82 ml higher FVC (Chuwers et al, 1997) . A difference of 0.29 mmolal plasma b-carotene in our study would be associated with a 46 ml higher FEV 1 , and a 93 ml higher FVC. So, the difference in FVC for a high vs a low plasma b-carotene level but not the difference in FEV 1 , was comparable with Chuwers et al (Chuwers et al, 1997) .
In the present study, a high vs a low plasma b-carotene concentration of 0.46 mmolal (90th vs 10th percentile) was associated with a 73 ml higher FEV 1 and a 147 ml higher FVC. The observed difference in FEV 1 for a high versus low plasma b-carotene level was not statistically signi®-cant, which might be because of a lack of power in our study. The difference in FEV 1 was, however, similar to the observed difference in FEV 1 (50 to 100 ml) in larger studies for high vs low dietary intake of vitamin C (Schwartz & Weiss, 1994; Britton et al, 1995; Grievink et al, 1998) and b-carotene (Grievink et al, 1998) . In addition, a 73 ml difference of FEV 1 , was about equivalent to three times the annual decline of FEV 1 (25 ml) in non-smoking Dutch adults (Xu et al, 1995) . Furthermore, the difference was approximately equivalent to the adverse effects of 5 years of heavy smoking ( 25 cigarettes per day) on FEV 1 , decline in Dutch adults (Xu et al, 1994) .
The present study did not show an association between plasma a-tocopherol and lung function. These results are consistent with one small follow-up study (83 men); serum levels of a-tocopherol were not associated with the development of airway obstruction (FEV 1 75% FVC) during 5 subsequent years (Morabia et al, 1990) . In addition, in large studies (n b 2500) dietary vitamin E was not independent of other dietary antioxidants associated with lung function (Britton et al, 1995; Grievink et al, 1998) . So far, there is no evidence that a-tocopherol levels in blood are related to lung function.
In conclusion, the results of the present study suggest that subjects with a high plasma b-carotene concentration tended to have a higher FVC than subjects with a low plasma b-carotene concentration. The difference in FEV 1 between those subjects with high and low plasma bcarotene levels tended to be in the same positive direction as that of FVC but did not reach the pre-set statistical signi®cance level. Plasma a-tocopherol concentration was not related to lung function.
